APA (7th ed.) Citation

Tang, W. W., Nemet, I., Li, X. S., Wu, Y., Haghikia, A., Witkowski, M., . . . Hazen, S. L. (2024). Prognostic value of gut microbe‐generated metabolite phenylacetylglutamine in patients with heart failure. European Journal of Heart Failure, 26(2), 233. https://doi.org/10.1002/ejhf.3111

Chicago Style (17th ed.) Citation

Tang, W.H. Wilson, et al. "Prognostic Value of Gut Microbe‐generated Metabolite Phenylacetylglutamine in Patients with Heart Failure." European Journal of Heart Failure 26, no. 2 (2024): 233. https://doi.org/10.1002/ejhf.3111.

MLA (9th ed.) Citation

Tang, W.H. Wilson, et al. "Prognostic Value of Gut Microbe‐generated Metabolite Phenylacetylglutamine in Patients with Heart Failure." European Journal of Heart Failure, vol. 26, no. 2, 2024, p. 233, https://doi.org/10.1002/ejhf.3111.